Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample.
Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases.
Contact us
ir@nightingalehealth.com
Half-year report 1 July - 31 December 2024 has been published
Latest releases
Nightingale Health Plc: Resolutions of the Extraordinary General Meeting and the Board of Directors’ organizational meeting
Nightingale Health Group’s Half-year report 1 July 2022 – 31 December 2022: Commercialization progressing in line with strategy
Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods
Nightingale Health to publish half-year report for July – December 2022 on 23 March 2023
Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples
Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service
Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™
Nightingale Health Plc – Managers’ transactions – Leena Niemistö
Subscribe to releases.
Get the latest Nightingale Health releases delivered straight to your inbox.